Abstract
To investigate the pharmacokinetics, effectiveness, and safety of subcutaneous (SC) abatacept treatment over 24 months in patients with polyarticular-course juvenile idiopathic arthritis (JIA). In this phase III, open-label, international, multicenter, single-arm study, patients with polyarticular JIA (cohort 1, ages 6-17 years and cohort 2, ages 2-5 years) in whom treatment with ≥1 disease-modifying antirheumatic drug was unsuccessful received weight-tiered SC abatacept weekly: 10 to <25 kg (50 mg), 25 to <50 kg (87.5 mg), ≥50 kg (125 mg). Patients who had met the JIA-American College of Rheumatology 30% improvement criteria (achieved a JIA-ACR 30 response) at month 4 were given the option to continue SC abatacept to month 24. The primary end point was the abatacept steady-state serum trough concentration (Cminss ) in cohort 1 at month 4. Other outcome measures included JIA-ACR 30, 50, 70, 90, 100, and inactive disease status, the median Juvenile Arthritis Disease Activity Score in 71 joints using the C-reactive protein level (JADAS-71-CRP) over time, safety, and immunogenicity. The median abatacept Cminss at month 4 (primary end point) and at month 24 was above the target therapeutic exposure (10 μg/ml) in both cohorts. The p...Continue Reading
References
Jul 1, 1997·Arthritis and Rheumatism·E H GianniniA Martini
Mar 16, 2000·The New England Journal of Medicine·D J LovellB K Finck
Feb 5, 2005·Arthritis and Rheumatism·Earl SilvermanVibeke Strand
Apr 22, 2005·The New England Journal of Medicine·Earl SilvermanUNKNOWN Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group
Mar 6, 2007·Lancet·Angelo Ravelli, Alberto Martini
Sep 1, 2007·Arthritis and Rheumatism·Nicolino RupertoUNKNOWN Pediatric Rheumatology Collaborative Study Group
Oct 9, 2007·Annals of the Rheumatic Diseases·M C GenoveseM Dougados
Apr 3, 2008·Arthritis and Rheumatism·Joel M KremerRené Westhovens
Jul 18, 2008·Lancet·Nicolino RupertoUNKNOWN Pediatric Rheumatology Collaborative Study Group
Aug 22, 2008·The New England Journal of Medicine·Daniel J LovellUNKNOWN Pediatric Rheumatology International Trials Organisation
Mar 11, 2009·The Journal of Rheumatology·Rene WesthovensMaxime Dougados
May 1, 2009·Arthritis and Rheumatism·Alessandro ConsolaroUNKNOWN Paediatric Rheumatology International Trials Organisation
Mar 2, 2010·Arthritis and Rheumatism·Nicolino RupertoUNKNOWN Paediatric Rheumatology International Trials Organization and the Pediatric Rheumatology Collaborative Study Group
Feb 15, 2011·Archives of Disease in Childhood·Nicolino Ruperto, Alberto Martini
Apr 1, 2011·Arthritis Care & Research·Timothy BeukelmanNicolino Ruperto
May 28, 2011·Arthritis and Rheumatism·M C GenoveseR Alten
Jul 1, 2011·Arthritis Care & Research·Carol A WallaceUNKNOWN Paediatric Rheumatology International Trials Organisation
Jan 11, 2012·Arthritis and Rheumatism·Alessandro ConsolaroUNKNOWN Paediatric Rheumatology International Trials Organization
Jan 20, 2012·Annals of the Rheumatic Diseases·E B NordalM Rygg
Apr 9, 2014·Modern Rheumatology·Mitsuhiro IwahashiTsutomu Takeuchi
May 20, 2014·Annals of the Rheumatic Diseases·Hermine I BrunnerUNKNOWN Pediatric Rheumatology Collaborative Study Group (PRCSG)
Jun 23, 2015·Arthritis & Rheumatology·Daniel J LovellUNKNOWN Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation
Jul 7, 2015·Current Opinion in Rheumatology·Kate Webb, Lucy R Wedderburn
Oct 25, 2016·Seminars in Arthritis and Rheumatism·Fahd AdeebAlexander Duncan Fraser
May 6, 2017·Annals of the Rheumatic Diseases·Philip J MeaseDafna D Gladman
May 17, 2017·Annals of the Rheumatic Diseases·Hermine I BrunnerUNKNOWN Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group
Citations
Jan 27, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Simon GlatignyEstelle Bettelli
Feb 28, 2019·Rheumatology·Martijn J H DoelemanJoost F Swart
Nov 2, 2019·Paediatric Drugs·Ivan Foeldvari
Sep 18, 2020·Nature Reviews. Drug Discovery·Natalie M EdnerLucy S K Walker
Jun 18, 2019·Expert Opinion on Drug Safety·C Diener, G Horneff
May 18, 2019·Zeitschrift für Rheumatologie·Gerd Horneff
Feb 24, 2020·Pediatric Rheumatology Online Journal·Hermine I BrunnerUNKNOWN Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation
Oct 28, 2019·Annals of Laboratory Medicine·Maurizio BenucciRoberto Verna
Aug 5, 2020·Nature Immunology·Natalie M EdnerLucy S K Walker
May 16, 2020·Medicina·Francesca MoriCarlo Caffarelli
Feb 12, 2019·Frontiers in Immunology·Romy E Hoeppli, Anne M Pesenacker
Oct 9, 2020·Paediatric Drugs·Hermine I BrunnerUNKNOWN Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group
Oct 23, 2020·Arthritis Care & Research·Chiara Trincianti, Alessandro Consolaro
Dec 8, 2020·Journal of Clinical Pharmacology·Yash GandhiBindu Murthy
Dec 29, 2020·Rheumatology·Suzanne C LiC Egla Rabinovich
Jan 26, 2021·Rheumatology·Nicolino RupertoUNKNOWN Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (
Nov 18, 2020·Trends in Molecular Medicine·Christopher D NishimuraXingxing Zang
Jul 19, 2020·Molecular Immunology·Shima AfzaliAliakbar Amirzargar
May 26, 2021·Pediatric Research·Erdal SagBent Deleuran
Jul 1, 2021·Therapeutic Advances in Musculoskeletal Disease·Chinar R ParikhCoziana Ciurtin
Jul 17, 2021·Human Vaccines & Immunotherapeutics·Shannon E MacDonaldCatherine Burton
Sep 19, 2020·Current Rheumatology Reviews·Ioanna G SaougouAlexandros A Drosos
Nov 19, 2021·ACR Open Rheumatology·Johanna R MoraMargarita Askelson